Anticoagulation in pediatric cancer–associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr

Anticoagulant treatment of pediatric cancer–associated venous thromboembolism (VTE) has not been prospectively evaluated. Management of anticoagulation for cancer-associated VTE is often challenged by drug interactions and treatment interruptions. A total of 56 of the 500 children (11.2%) with VTE w...

Descripción completa

Detalles Bibliográficos
Autores principales: Palumbo, Joseph S., Lensing, Anthonie W.A., Brandão, Leonardo R., Hooimeijer, Hélène L., Kenet, Gili, van Ommen, Heleen, Pap, Akos F., Majumder, Madhurima, Kubitza, Dagmar, Thelen, Kirstin, Willmann, Stefan, Prins, Martin H., Monagle, Paul, Male, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641171/
https://www.ncbi.nlm.nih.gov/pubmed/36006613
http://dx.doi.org/10.1182/bloodadvances.2022008160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641171/
https://www.ncbi.nlm.nih.gov/pubmed/36006613
http://dx.doi.org/10.1182/bloodadvances.2022008160

Ejemplares similares